Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/8047
Full metadata record
DC FieldValueLanguage
dc.contributor.authorEatock, J-
dc.contributor.authorDixon, D-
dc.contributor.authorYoung, T-
dc.date.accessioned2014-02-18T16:46:56Z-
dc.date.available2014-02-18T16:46:56Z-
dc.date.issued2009-
dc.identifier.citationJournal of Manufacturing Technology Management, 20(2), 218 - 234, 2009en_US
dc.identifier.issn1741-038X-
dc.identifier.urihttp://www.emeraldinsight.com/journals.htm?articleid=1770979&show=abstracten
dc.identifier.urihttp://bura.brunel.ac.uk/handle/2438/8047-
dc.descriptionThis article is (c) Emerald Group Publishing and permission has been granted for this version to appear here. Emerald does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from Emerald Group Publishing Limited.en_US
dc.description.abstractPurpose – This study seeks to examine the extent to which mainstream tools and strategies are applied in the medical devices sector, which is highly fragmented and contains a high percentage of small companies, and to determine if company size impacts on manufacturing strategy selection. Design/methodology/approach – A questionnaire was developed and disseminated through a number of channels. Responses were received from 38 companies in the UK and Ireland, describing 68 products taken to market in the past five years. Findings – Because of the limited scope of the survey, the findings are indicative rather than conclusive, and interesting trends have emerged. New to the world products were much more likely to exceed company expectations of market success compared to derivative products. It was found that the majority of these innovative products were developed by small companies. Large companies appear to favour minor upgrades over major upgrades even though these prove – on the data presented – to be less successful overall. Practical implications – These results provide those engaged in this sector with comparative information and some insights for further improvement. The reported trends with respect to company size and product complexity (or degree of novelty) are particularly illuminating. Academically, this sets some expected trends on a firmer footing and unearths one or two unexpected findings. Originality/value – It is believed that this is the largest survey of determinants of success in UK medical device companies and it provides a comparison with other sectors.en_US
dc.language.isoenen_US
dc.publisherEmerald Group Publishing Limiteden_US
dc.subjectCorporate strategyen_US
dc.subjectManufacturing industriesen_US
dc.subjectMedical equipmenten_US
dc.titleAn exploratory survey of current practice in the medical device industryen_US
dc.typeArticleen_US
dc.identifier.doihttp://dx.doi.org/10.1108/17410380910929637-
pubs.organisational-data/Brunel-
pubs.organisational-data/Brunel/Brunel Active Staff-
pubs.organisational-data/Brunel/Brunel Active Staff/School of Info. Systems, Comp & Maths-
pubs.organisational-data/Brunel/Brunel Active Staff/School of Info. Systems, Comp & Maths/IS and Computing-
pubs.organisational-data/Brunel/University Research Centres and Groups-
pubs.organisational-data/Brunel/University Research Centres and Groups/School of Information Systems, Computing and Mathematics - URCs and Groups-
pubs.organisational-data/Brunel/University Research Centres and Groups/School of Information Systems, Computing and Mathematics - URCs and Groups/Centre for Information Systems Research-
pubs.organisational-data/Brunel/University Research Centres and Groups/School of Information Systems, Computing and Mathematics - URCs and Groups/Multidisclipary Assessment of Technology Centre for Healthcare (MATCH)-
Appears in Collections:Publications
Computer Science
Dept of Computer Science Research Papers

Files in This Item:
File Description SizeFormat 
Fulltext.pdf519.55 kBAdobe PDFView/Open


Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.